Novo Nordisk will begin a new late-stage trial of its experimental next-generation obesity drug CagriSema on Feb. 10, according to a entry.

Northwell Health partnered with Stacker to examine data from the CDC, Pew, and other sources to compile research on alcohol consumption and its health impact.

An analyst thinks he has cracked the code on why highflying Eli Lilly missed two quarters of Wall Street projections.

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

Growing demand for weight-loss solutions has catapulted pharmaceutical firms like Eli Lilly (LLY) and Novo Nordisk (NVO) into ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and ...

As Amanda Phommachanh, a 45-year-old realtor in Manassas, Virginia, describes it, she was on track with Wegovy to meet her ...

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are ...

Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.

The radio queen went for a dip at Sydney 's Clovelly beach where she did laps in the tide pool. The 49-year-old showed off ...

Gypsy Rose Blanchard hit back at rumors that Child Protective Services was called to check on her baby Aurora Urker, as well ...